OPEN TO ALL

UMDF Bench-to-Bedside Seminar
Mitochondrial Replacement Therapy (MRT): Shared Experiences from the UK & Australia and Implications in the US
​​​​​​
Friday, Sept. 5 at 10:00 am ET

Last month, researchers in the United Kingdom published two papers sharing promising results from eight births utilizing mitochondrial replacement therapy, a fertility technique that helps prevent the transmission of mitochondrial disease to future generations. The technique involves transferring the nuclear DNA from a mother’s fertilized egg into a fertilized donor egg with healthy mitochondria, resulting in a child who is genetically related to both parents but with a much lower risk of inheriting mitochondrial disease. The technique is currently legal to use in clinical research in the UK and Australia, but not in the United States.

All — patients, families, clinicians, and researchers — are welcome to join us for a special MRT-focused Bench-to-Bedside on September 5 at 10am ET featuring non-profit leaders and clinicians who have personal experience with the science and political components of MRT, including: ​​​​​

Moderator:
Philip E. Yeske, PhD, UMDF Science & Alliance Officer

Speakers/Panelists:
Sean Murray, Mito Foundation CEO
Clare Stuart, Mito Foundation Policy and Advocacy Manager
Clair Wright, Lily Foundation
Michio Hirano, MD, Columbia University Medical Center
Dieter Egli, PhD, Columbia Stem Cell Initiative
Robert McFarland, MA MBBS PhD MRCP MRCPH, Director of the NHS Highly Specialised Service for Rare Mitochondrial Disorders
Mary Herbert, PhD, Monash Biomedicine Discovery Institute

Please register using the below link. Questions can be submitted before the seminar here.